Integra Lifesciences Holdings (IART) Return on Capital Employed (2010 - 2026)

Integra Lifesciences Holdings (IART) has 17 years of Return on Capital Employed data on file, last reported at 14.38% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 1467.0% year-over-year to 14.38%; the trailing twelve-month figure through Mar 2026 stood at 14.38% (down 1467.0% YoY), and the FY2025 full-year result was 14.67%, down 1562.0% from the prior year.
• Return on Capital Employed grew to 14.38% in Q1 2026, from 15.57% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 6.77% in Q4 2022 to a low of 17.09% in Q2 2025.
• A 5-year average of 0.61% and a median of 2.18% in 2024 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed jumped 149 bps in 2022 and tumbled 1878 bps in 2025, its largest moves.
• Tracing IART's Return on Capital Employed over 5 years: stood at 6.77% in 2022, then tumbled by 52 bps to 3.23% in 2023, then tumbled by 72 bps to 0.91% in 2024, then slumped by 1815 bps to 15.57% in 2025, then gained by 8 bps to 14.38% in 2026.
• Business Quant data shows IART's Return on Capital Employed at 14.38% in Q1 2026, 15.57% in Q4 2025, and 14.6% in Q3 2025.